Vanguard Group Inc Takes Position in OptimizeRx Co. (OPRX)

Vanguard Group Inc bought a new position in shares of OptimizeRx Co. (NASDAQ:OPRX) during the 3rd quarter, according to its most recent …

OptimizeRx logoVanguard Group Inc bought a new position in shares of OptimizeRx Co. (NASDAQ:OPRX) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 289,123 shares of the company’s stock, valued at approximately $5,204,000. Vanguard Group Inc owned 2.41% of OptimizeRx at the end of the most recent quarter.

Shares of OPRX stock traded up $0.26 during trading on Tuesday, hitting $13.06. The company’s stock had a trading volume of 1,629 shares, compared to its average volume of 62,232. The firm has a market cap of $151.50 million, a PE ratio of -62.19, a P/E/G ratio of 2.70 and a beta of 0.93. OptimizeRx Co. has a 52 week low of $2.30 and a 52 week high of $18.39.

Several equities analysts have recently issued reports on OPRX shares. Zacks Investment Research lowered OptimizeRx from a “buy” rating to a “hold” rating in a report on Tuesday, October 23rd. William Blair started coverage on OptimizeRx in a report on Thursday, January 3rd. They issued an “outperform” rating for the company. Five analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and a consensus target price of $18.25.

COPYRIGHT VIOLATION WARNING: “Vanguard Group Inc Takes Position in OptimizeRx Co. (OPRX)” was first reported by Fairfield Current and is the sole property of of Fairfield Current. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright legislation. The legal version of this piece can be accessed at

OptimizeRx Company Profile

OptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria.

Further Reading: QQQ ETF

Want to see what other hedge funds are holding OPRX?Visit to get the latest 13F filings and insider trades for OptimizeRx Co. (NASDAQ:OPRX).

Receive News & Ratings for OptimizeRx Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for OptimizeRx and related companies with’s FREE daily email newsletter.

Related Posts:

  • No Related Posts